Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Visium Asset Management, Soros Fund Management, Citadel, Casa Systems Inc (CASA), Andeavor (ANDV), and More

Insider Selling: Casa Systems (NASDAQ:CASA) Director Sells 4,717,520 Shares of Stock (WeekHerald.com)
Casa Systems Inc (NASDAQ:CASA) Director Peter Y. Chung sold 4,717,520 shares of Casa Systems stock in a transaction dated Monday, April 30th. The shares were sold at an average price of $25.00, for a total value of $117,938,000.00. The transaction was disclosed in a filing with the SEC.

Insider Selling: Andeavor (NYSE:ANDV) Director Sells 109,275 Shares of Stock (RegistrarJournal.com)
Andeavor (NYSE:ANDV) Director Jeff A. Stevens sold 109,275 shares of Andeavor stock in a transaction that occurred on Friday, April 27th. The shares were sold at an average price of $123.19, for a total transaction of $13,461,587.25. Following the completion of the transaction, the director now owns 1,196,578 shares of the company’s stock, valued at approximately $147,406,443.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

Insider Selling: Shake Shack (NYSE:SHAK) CEO Sells 20,000 Shares of Stock (WeekHerald.com)
Shake Shack Inc (NYSE:SHAK) CEO Randall J. Garutti sold 20,000 shares of the stock in a transaction that occurred on Thursday, April 26th. The stock was sold at an average price of $44.98, for a total value of $899,600.00. Following the completion of the transaction, the chief executive officer now owns 38,041 shares of the company’s stock, valued at $1,711,084.18. The sale was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Hemispherx Biopharma (HEB) CEO Purchases 32,000 Shares of Stock (StockNewsTimes.com)
Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) CEO Thomas K. Equels bought 32,000 shares of the company’s stock in a transaction that occurred on Friday, April 27th. The shares were purchased at an average cost of $0.32 per share, for a total transaction of $10,240.00. Following the acquisition, the chief executive officer now owns 524,919 shares of the company’s stock, valued at $167,974.08. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Insider Selling: NovoCure (NASDAQ:NVCR) CTO Sells 19,362 Shares of Stock (RegistrarJournal.com)
Novocure Ltd (NASDAQ:NVCR) CTO Yoram Palti sold 19,362 shares of the stock in a transaction dated Friday, April 20th. The stock was sold at an average price of $25.06, for a total transaction of $485,211.72. The sale was disclosed in a document filed with the SEC.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.